Please review the following CME information before selecting the Begin the Program button found at the bottom of this page.
NEEDS ASSESSMENT
The natural aging process— when fat and collagen under the skin begins to diminish— affects each individual differently. Many people find that the impact of aging negatively impacts their quality of life; therefore, they seek treatment to improve their appearance.
Physicians have many treatment options, surgical and non-surgical, when addressing aging of the skin. Soft tissue fillers, which are among the non-surgical group, are often considered the first line in the treatment of aging skin and are frequently used in combinations or with other techniques for facial rejuvenation. A variety of filler substances exist that address a wide range of cosmetic flaws, each bringing subtle, distinctive benefits. In some patients, more than one filler may be used to achieve the best results as some fillers.
With several filler options available physicians need to be aware of the benefits and potential risk of each. Filling substances commonly used by dermatologists include collagen, autologus fat, poly-L-lactic acid, calcium hydroxyapatite, and hyaluronic acid. Hyaluronic acid replaces lost volume and restores youthful contours to the skin to smooth away moderate to severe facial wrinkles and folds. Hyaluronic acid is a natural component of human skin and is the framework in which skin cells live. There are several hyaluronic acid products available with each having various characteristics, although all hyaluronic acid products bind water and give the skin volume.
Since each patient needs to be treated individually, physicians need to tailor their choice of dermal filler to the patient as well as learn proper injection techniques to avoid complications. To do so, dermatologists, plastic surgeons and other healthcare professionals need to stay up-to-date on the latest innovations in the filler arena, as well as be proficient in injection technique.
Intended Audience
This activity has been developed for dermatologists, plastic surgeons, fellows and residents in plastic surgery and dermatology.
EDUCATIONAL OBJECTIVES
Upon completion of this activity , participants should be able to:
- Discuss the causes, processes, and sites of facial biometric volume loss
- Demonstrate knowledge of the treatment options for correcting facial biometric volume loss, including recently approved and investigational agents, and state the differences between stimulatory and replacement fillers
- Compare the indications, side effects, and contraindications of the different filler options
- Describe as well as employ the various injections techniques and the benefits and potential risks of each.
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Elsevier Office of Continuing Medical Education (EOCME) and Skin Disease Education Foundation (SDEF). The EOCME is accredited by the ACCME to provide continuing medical education (CME) for physicians.
CME Credit Statement
The EOCME designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
FACULTY DISCLOSURES
As a sponsor accredited by the ACCME, it is the policy of the EOCME to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity. The faculty of this educational activity discloses the following.
Dr Comstock is a speaker for Allergan, Obagi, and Medicis. Dr Michaels has nothing to disclose.
Educational Reviewer: Robert Reina, MS, MBA has nothing to disclose.
Resolution of conflict of Interest
The EOCME has implemented a process to resolve conflict of interest for each CME activity. In order to help ensure content objectivity, independence, and fair balance, and to ensure that the content is aligned with the interest of the public, the EOCME has resolved the conflict by external content review.
Unapproved/Off-Label Use Disclosure
The EOCME requires CME faculty to disclose to the participants:
- When products or procedures being discussed are off-label, unlabeled, experimental, and or investigational (not US Food and Drug Administration [FDA] approved); and
- Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research; interim analyses; and/or unsupported opinion.
Faculty may discuss information about pharmaceutical agents that are outside of FDA-approved labeling. This information is intended solely for CME and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
FINANCIAL SUPPORT
This CME activity is supported by an educational grant from 
.
Special Needs
We encourage participation by all individuals. If you have any special needs, please contact mededinfo@elsevier.com for assistance.
Hardware and Software Specifications Needed to View
This course requires use of a modern web browser such as Microsoft Internet Explorer, Mozilla Firefox, Apple Safari, Netscape, or Opera. Additionally, to view the presentations requires Flash reader version 6 or later (free download here) and Acrobat Reader Version 5 or later (free download here).